☆ 4.6 Article

A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2

NPJ VACCINES (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Respiratory System

Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19

James P. Bridges et al.

Summary: COVID-19 infection in the lungs progresses through different stages with distinct characteristics, and effective therapy relies on the specific location and extent of infection. The virus targets different cell types in the conducting airways and gas exchange portions of the lung, requiring tailored therapeutic approaches. Alveolar infection can lead to acute respiratory distress syndrome and a hyperinflammatory state, necessitating specific therapies in severe cases.

THORAX (2022)

添加到收藏夹

Article Microbiology

Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models

Min-Wen Ku et al.

Summary: Vaccination using a lentiviral vector to induce neutralizing antibodies against SARS-CoV-2 provides partial protection when administered systemically, but intranasal immunization results in a significant decrease in lung viral load and reduced local inflammation. Integrative and non-integrative lentiviral platforms both show strong vaccine efficacy against COVID-19 in golden hamsters, highlighting the potential of intranasal vaccination as a powerful approach.

CELL HOST & MICROBE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Correlates of protection against SARS-CoV-2 in rhesus macaques

Katherine McMahan et al.

Summary: Adoptive transfer of purified IgG from convalescent macaques protects naive macaques against SARS-CoV-2 infection, and cellular immune responses contribute to protection against rechallenge with SARS-CoV-2. The findings suggest that relatively low antibody titres are sufficient for protection against SARS-CoV-2 in macaques, while higher antibody titres are required for treatment of SARS-CoV-2 infection.

NATURE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Neutralizing antibody titres in SARS-CoV-2 infections

Eric H. Y. Lau et al.

Summary: In this study, researchers quantified SARS-CoV-2 specific neutralizing antibodies using plaque reduction neutralization (PRNT) assays on 195 patients in different disease states. They found that patients with severe disease had higher peaks of neutralizing antibody titres than patients with mild or asymptomatic infections, and that serum neutralizing antibody persists for over 6 months in most people.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Microbiology

Robust SARS-CoV-2 infection in nasal turbinates after treatment with systemic neutralizing antibodies

Dongyan Zhou et al.

Summary: Human neutralizing antibodies demonstrated effective inhibition of SARS-CoV-2 infection in the lungs but were less effective in nasal turbinates, indicating implications for subprotection, reinfection, and vaccine development.

CELL HOST & MICROBE (2021)

添加到收藏夹

Article Medicine, General & Internal

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey et al.

Summary: The AZD1222 vaccine has been approved for emergency use in the UK with an interval of 4-12 weeks between doses. Analysis shows that the vaccine is efficacious with two doses and provides immunoprotection after the first dose before the second dose is administered.

LANCET (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Denis Y. Logunov et al.

Summary: The Gam-COVID-Vac vaccine showed 91.6% efficacy against COVID-19 in the phase 3 trial, with good safety and tolerability in a large cohort of participants.

LANCET (2021)

添加到收藏夹

Article Multidisciplinary Sciences

A safe and highly efficacious measles virus-based vaccine expressing SARS-CoV-2 stabilized prefusion spike

Mijia Lu et al.

Summary: Using a measles virus vaccine strain as the backbone, researchers developed a series of recombinant attenuated vaccine candidates expressing various forms of the SARS-CoV-2 spike protein. Among these candidates, rMeV expressing stabilized prefusion S protein showed the highest potency in inducing neutralizing antibodies and provided complete protection against SARS-CoV-2 in animal models. This supports further development of rMeV-preS as a highly effective vaccine candidate against SARS-CoV-2.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

添加到收藏夹

Article Cell Biology

Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients

Yang Li et al.

Summary: By analyzing the serum IgG response of 1,051 COVID-19 patients, researchers identified linear epitopes of the SARS-CoV-2 Spike protein, revealing two regions rich in linear epitopes and identifying variable peptide responses associated with disease severity. Antibodies obtained from immunizing mice with linear epitopes did not show significant neutralizing activity against the virus, suggesting the importance of understanding humoral responses for vaccine refinement.

CELL REPORTS (2021)

添加到收藏夹

Article Virology

Proteases and variants: context matters for SARS-CoV-2 entry assays

Christian S. Stevens et al.

Summary: This review explores the complexity of SARS-CoV-2 entry pathways and their implications on entry assays, emphasizing the importance of proteolytic activation in understanding emerging variants. The authors advocate for better universal standards for virus entry assays and suggest best practices for reporting viral passage number, cell lines used, and proteases present.

CURRENT OPINION IN VIROLOGY (2021)

添加到收藏夹

Editorial Material Biochemistry & Molecular Biology

SARS-CoV-2 escaped natural immunity, raising questions about vaccines and therapies

Emanuele Andreano et al.

Summary: While SARS-CoV-2 is capable of evading natural immune responses, the question remains whether the virus can escape monoclonal antibodies and vaccine-induced immunity.

NATURE MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

David S. Khoury et al.

Summary: The level of neutralizing antibodies is closely related to immune protection against COVID-19, playing a crucial role in protecting against detected infection and severe infection. Studies have shown that neutralizing titers will decline over time after vaccination, leading to decreased protection against SARS-CoV-2 infection.

NATURE MEDICINE (2021)

添加到收藏夹

Article Microbiology

Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model

Drishya Kurup et al.

Summary: The study developed an inactivated rabies virus vectored vaccine platform, resulting in a vaccine against SARS-CoV-2 named CORAVAX. CORAVAX demonstrated effectiveness in preventing viral replication and lung disease in hamster models, showing potential for robust immune responses in humans.

PLOS PATHOGENS (2021)

添加到收藏夹

Article Microbiology

Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization

Alexandru A. Hennrich et al.

Summary: The study focuses on developing a safe single round rhabdovirus replicon vaccine platform for enhanced presentation of the S receptor-binding domain (RBD). A chimeric minispike was designed to simultaneously present the antigen on cell surface and virus-like particles, leading to high titers of SARS-CoV-2 neutralizing antibodies and protection against COVID-19-like disease in mice. The results demonstrate that non-spreading rhabdovirus RNA replicons expressing minispike proteins provide an effective and safe alternative to traditional vaccination approaches.

PLOS PATHOGENS (2021)

添加到收藏夹

Review Microbiology

The success of SARS-CoV-2 vaccines and challenges ahead

Kanta Subbarao

Summary: The development of effective SARS-CoV-2 vaccines is facing challenges in preventing asymptomatic and mild infections, potential updates required due to the emergence of variants with mutations, and concerns about the longevity of vaccine-induced immunity. Coordination in global surveillance, updating vaccines, and potential re-vaccination may be necessary to address these challenges.

CELL HOST & MICROBE (2021)

添加到收藏夹

Article Medicine, General & Internal

SARS-CoV-2 Variants and Vaccines

Philip R. Krause et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung

Nanda Kishore Routhu et al.

Summary: Efficient vaccines for SARS-CoV-2 are urgently needed, and the trimeric form of the receptor-binding domain of the virus spike protein combined with alum-3M-052 adjuvant has been shown to protect non-human primates from the disease and inhibit infection.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Cell Biology

An intranasal vaccine durably protects against SARS-CoV-2 variants in mice

Ahmed O. Hassan et al.

Summary: Intranasal immunization with ChAd-SARS-CoV-2-S in mice induces durable neutralizing and Fc effector antibody responses, providing protection against historical and emerging SARS-CoV-2 strains.

CELL REPORTS (2021)

添加到收藏夹

Article Cell Biology

A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters

Traci L. Bricker et al.

Summary: The study found that intranasal administration provides superior protection against SARS-CoV-2 infection and inflammation in the upper respiratory tract compared to intramuscular injection, reducing weight loss, viral infection, and lung pathology. Therefore, intranasal delivery of ChAd-SARS-CoV-2-S candidate vaccine is supported for preventing SARS-CoV-2 infection.

CELL REPORTS (2021)

添加到收藏夹

Article Virology

Animal models for SARS-CoV-2

Chung-Young Lee et al.

Summary: The urgent development of anti-viral therapeutics and vaccines for the novel coronavirus requires appropriate animal models to accelerate research. Different animal models have unique features, necessitating a careful selection based on study goals.

CURRENT OPINION IN VIROLOGY (2021)

添加到收藏夹

Editorial Material Microbiology

SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse

Frank Konings et al.

Summary: A group convened and led by the Virus Evolution Working Group of the World Health Organization has announced a naming scheme to enable clear communication about SARS-CoV-2 variants of interest and concern.

NATURE MICROBIOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine

Dong An et al.

Summary: This mucosal vaccine strategy inhibits SARS-CoV-2 replication in the upper respiratory tract, preventing disease transmission. The vaccine candidate CVXGA1 shows promising protective effects in animal models.

SCIENCE ADVANCES (2021)

添加到收藏夹

Article Immunology

A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19

Delphine C. Malherbe et al.

Summary: The study developed a SARS-CoV-2 ConVac vaccine which, through animal experiments, showed that a single dose of the vaccine could rapidly control viral replication after disease challenge, protecting animals from weight loss and lung virus replication, with some inflammation still detected.

NPJ VACCINES (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Attenuated activation of pulmonary immune cells in mRNA-1273-vaccinated hamsters after SARS-CoV-2 infection

Michelle Meyer et al.

Summary: The study demonstrates that the mRNA-1273 vaccine is effective in hamsters against SARS-CoV-2, inducing robust neutralizing antibodies and reducing disease severity. It also shows the impact of the vaccine on immune cell infiltration, lymphocyte proportion, and antiviral responses conducive to lung health.

JOURNAL OF CLINICAL INVESTIGATION (2021)

添加到收藏夹

Article Cell Biology

A single intranasal dose of chimpanzee adenovirus-vectored vaccine protects against SARS-CoV-2 infection in rhesus macaques

Ahmed O. Hassan et al.

Summary: The study demonstrates the immunogenicity and protective efficacy of an intranasally administered vaccine in non-human primates, showing that it induces neutralizing antibodies and T cell responses, effectively limiting or preventing infection of SARS-CoV-2 in the respiratory tract.

CELL REPORTS MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

添加到收藏夹

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Daniel Wrapp et al.

SCIENCE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Alexandra C. Walls et al.

CELL (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann et al.

CELL (2020)

添加到收藏夹

Article Microbiology

Infection and Rapid Transmission of SARS-CoV-2 in Ferrets

Young-Il Kim et al.

CELL HOST & MICROBE (2020)

添加到收藏夹

Article Microbiology

An Infectious cDNA Clone of SARS-CoV-2

Xuping Xie et al.

CELL HOST & MICROBE (2020)

添加到收藏夹

Article Immunology

Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals

Ling Ni et al.

IMMUNITY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Site-specific glycan analysis of the SARS-CoV-2 spike

Yasunori Watanabe et al.

SCIENCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Development of an inactivated vaccine candidate for SARS-CoV-2

Qiang Gao et al.

SCIENCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

DNA vaccine protection against SARS-CoV-2 in rhesus macaques

Jingyou Yu et al.

SCIENCE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients

Chek Meng Poh et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Immunogenicity of a DNA vaccine candidate for COVID-19

Trevor R. F. Smith et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Viral and host factors related to the clinical outcome of COVID-19

Xiaonan Zhang et al.

NATURE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Structural basis of receptor recognition by SARS-CoV-2

Jian Shang et al.

NATURE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2

Hui Wang et al.

CELL (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

Lianpan Dai et al.

CELL (2020)

添加到收藏夹

Article Immunology

Analysis of a SARS-CoV-2-Infected Individual Reveals Development of Potent Neutralizing Antibodies with Limited Somatic Mutation

Emilie Seydoux et al.

IMMUNITY (2020)

添加到收藏夹

Article Immunology

The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients

Lakshmanane Premkumar et al.

SCIENCE IMMUNOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2

Ahmed O. Hassan et al.

CELL (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

Luca Piccoli et al.

CELL (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques

Noe B. Mercado et al.

NATURE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

Neeltje van Doremalen et al.

NATURE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

Davide F. Robbiani et al.

NATURE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Lihong Liu et al.

NATURE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

A thermostable, closed SARS-CoV-2 spike protein trimer

Xiaoli Xiong et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

Masaki Imai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

添加到收藏夹

Article Multidisciplinary Sciences

SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses

He-wei Jiang et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Medicine, General & Internal

Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Cheryl Keech et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Multidisciplinary Sciences

An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques

Liqiang Feng et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge

Shipo Wu et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States

Jennifer Harcourt et al.

EMERGING INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Virology

Achieving cross-reactivity with pan-ebolavirus antibodies

Liam B. King et al.

CURRENT OPINION IN VIROLOGY (2019)

添加到收藏夹

Article Biochemical Research Methods

Pathway-level information extractor (PLIER) for gene expression data

Weiguang Mao et al.

NATURE METHODS (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Gene expression profiling of single cells from archival tissue with laser-capture microdissection and Smart-3SEQ

Joseph W. Foley et al.

GENOME RESEARCH (2019)

添加到收藏夹

Article Virology

Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine

J. Brian Kimble et al.

JOURNAL OF VIROLOGY (2019)

添加到收藏夹

Article Microbiology

Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap

Philipp A. Ilinykh et al.

PLOS PATHOGENS (2018)

添加到收藏夹

Article Immunology

Induction of regulatory T cells by Opisthorchis viverrini

C. Kaewraemruaen et al.

PARASITE IMMUNOLOGY (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

Davide Corti et al.

SCIENCE (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Structural and molecular basis for Ebola virus neutralization by protective human antibodies

John Misasi et al.

SCIENCE (2016)

添加到收藏夹

Review Respiratory System

Pulmonary macrophages: key players in the innate defence of the airways

Adam J. Byrne et al.

THORAX (2015)

添加到收藏夹

Article Virology

Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology

Yoshikazu Honda-Okubo et al.

JOURNAL OF VIROLOGY (2015)

添加到收藏夹

Article Biochemical Research Methods

featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

Yang Liao et al.

BIOINFORMATICS (2014)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

添加到收藏夹

Article Biochemical Research Methods

STAR: ultrafast universal RNA-seq aligner

Alexander Dobin et al.

BIOINFORMATICS (2013)

添加到收藏夹

Article Biochemical Research Methods

Pathview: an R/Bioconductor package for pathway-based data integration and visualization

Weijun Luo et al.

BIOINFORMATICS (2013)

添加到收藏夹

Article Multidisciplinary Sciences

Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus

Chien-Te Tseng et al.

PLOS ONE (2012)

添加到收藏夹

Review Immunology

Recent progress in mucosal vaccine development: potential and limitations

Nils Lycke

NATURE REVIEWS IMMUNOLOGY (2012)

添加到收藏夹

Article Virology

A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response

Meagan Bolles et al.

JOURNAL OF VIROLOGY (2011)

添加到收藏夹

Article Virology

Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic

Alexander A. Bukreyev et al.

VIROLOGY (2010)

添加到收藏夹

Article Biochemical Research Methods

GAGE: generally applicable gene set enrichment for pathway analysis

Weijun Luo et al.

BMC BIOINFORMATICS (2009)

添加到收藏夹

Article Biochemical Research Methods

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

Da Wei Huang et al.

NATURE PROTOCOLS (2009)

添加到收藏夹

Editorial Material Biochemistry & Molecular Biology

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

Da Wei Huang et al.

NUCLEIC ACIDS RESEARCH (2009)

添加到收藏夹

Article Virology

A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals

Lijuan Yang et al.

VIROLOGY (2008)

添加到收藏夹

Review Immunology

Exploring the full spectrum of macrophage activation

David M. Mosser et al.

NATURE REVIEWS IMMUNOLOGY (2008)

添加到收藏夹

Article Virology

Successful topical respiratory tract immunization of primates against ebola virus

Alexander Bukreyev et al.

JOURNAL OF VIROLOGY (2007)

添加到收藏夹

Review Virology

Nonsegmented negative-strand viruses as vaccine vectors

Alexander Bukreyev et al.

JOURNAL OF VIROLOGY (2006)

添加到收藏夹

Article Virology

A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge

A Bukreyev et al.

JOURNAL OF VIROLOGY (2006)

添加到收藏夹

Article Medicine, General & Internal

Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors

SW Liu et al.

LANCET (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.